| Title | Research Area | Implementing Organisations | Funding Organisations | Start Year | Status |
|---|---|---|---|---|---|
| Development of Processes for Active Pharmaceutical Ingredients towards COVID-19 | Pharmaceutical Sciences | CSIR-North East Institute of Science & Technology, Assam | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| Preparation of Certified Reference Material of important phytomolecules | Pharmaceutical Sciences | CSIR-National Botanical Research Institute (CSIR-NBRI), Lucknow | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| Novel and integrative approaches towards discovery of small molecule therapeutics for healthy ageing | Pharmaceutical Sciences | Central Drug Research Institute (CDRI) | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| Development of META1 as a druggable target against Leishmaniasis | Pharmaceutical Sciences | Centre for Cellular and Molecular Biology (CCMB) | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| Discovery of cannabinoids and their derivatives from Cannabis sativa for the management of chronic disease conditions like rheumatoid arthritis/neuropathic pain | Pharmaceutical Sciences | CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| IND enabling studies and development of CDRI-4655 as anti-hyper-triglyceridemic formulation | Pharmaceutical Sciences | CSIR-Central Drug Research Institute (CSIR-CDRI), Uttar Pradesh | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| Research in ASTHI: Pre-clinical development of CDRI optimized lead molecules as dual osteogenic and muscle anabolic agents | Pharmaceutical Sciences | Central Drug Research Institute (CDRI) | Council of Scientific & Industrial Research (CSIR) | 2020 | Completed |
| In-silico development of putative drugs for targeting SARS-CoV-2 Mpro | Pharmaceutical Sciences | Indian Institute of Technology (IIT), New Delhi | — | 2020 | — |
| Targeting n3CLPro main protease, spike surface protein of COVID-19 | Pharmaceutical Sciences | Indian Institute of Technology (IIT), New Delhi | — | 2020 | — |
| Computational Repurposing of Drugs/Synthetic Compounds for Inhibiting RNA-dependent RNA polymerase (RdRp) in COVID-19 Infection in Humans | Pharmaceutical Sciences | Maulana Azad National Institute of Technology | — | 2020 | — |
Accessibility Controls